Tandem Diabetes Care Total Current Liabilities 2012-2025 | TNDM
Tandem Diabetes Care total current liabilities from 2012 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Tandem Diabetes Care Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $247 |
| 2023 | $195 |
| 2022 | $165 |
| 2021 | $132 |
| 2020 | $104 |
| 2019 | $99 |
| 2018 | $66 |
| 2017 | $36 |
| 2016 | $31 |
| 2015 | $27 |
| 2014 | $18 |
| 2013 | $15 |
| 2012 | $17 |
| 2011 | $17 |
| Tandem Diabetes Care Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $288 |
| 2024-12-31 | $247 |
| 2024-09-30 | $259 |
| 2024-06-30 | $241 |
| 2024-03-31 | $193 |
| 2023-12-31 | $195 |
| 2023-09-30 | $187 |
| 2023-06-30 | $175 |
| 2023-03-31 | $171 |
| 2022-12-31 | $165 |
| 2022-09-30 | $174 |
| 2022-06-30 | $139 |
| 2022-03-31 | $132 |
| 2021-12-31 | $132 |
| 2021-09-30 | $120 |
| 2021-06-30 | $109 |
| 2021-03-31 | $103 |
| 2020-12-31 | $104 |
| 2020-09-30 | $106 |
| 2020-06-30 | $114 |
| 2020-03-31 | $100 |
| 2019-12-31 | $99 |
| 2019-09-30 | $100 |
| 2019-06-30 | $84 |
| 2019-03-31 | $77 |
| 2018-12-31 | $66 |
| 2018-09-30 | $59 |
| 2018-06-30 | $43 |
| 2018-03-31 | $44 |
| 2017-12-31 | $36 |
| 2017-09-30 | $29 |
| 2017-06-30 | $31 |
| 2017-03-31 | $29 |
| 2016-12-31 | $31 |
| 2016-09-30 | $35 |
| 2016-06-30 | $27 |
| 2016-03-31 | $25 |
| 2015-12-31 | $27 |
| 2015-09-30 | $22 |
| 2015-06-30 | $18 |
| 2015-03-31 | $19 |
| 2014-12-31 | $18 |
| 2014-09-30 | $16 |
| 2014-06-30 | $13 |
| 2014-03-31 | $13 |
| 2013-12-31 | $15 |
| 2013-09-30 | $20 |
| 2013-06-30 | $17 |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2011-12-31 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $1.331B | $0.940B |
| Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration. | |||